Reports related to this article:
The Pharmaceutical & Biotech Industry has well over 4,400 reported capital and maintenance projects on the books globally, with a healthy potential investment value of more than $87 billion.
Reported activity spans the entire spectrum of industry sectors, including projects like Pfizer's $450 million plan to add a modular aseptic processing (MAP) facility at its global manufacturing site in Kalamazoo, Michigan, and contract manufacturer Hovione's $232 million grassroot plant that would produce active pharmaceuticals ingredients (APIs) and other products for the European, Japanese and North American markets.
See project map below.
Want More IIR News Intelligence?
Make us a Preferred Source on Google to see more of us when you search.
Add Us On GoogleAsk Us
Have a question for our staff?
Submit a question and one of our experts will be happy to assist you.
Explore Our EnergyLive Tools
EnergyLive Tools provide instant insight into new build, outages, maintenance, and capacity shifts across key energy sectors.
Explore Our ToolsRelated Articles
-
Industrial Manufacturing Leads Michigan to $7.5 Billion in P...August 16, 2022
-
Pharmaceutical Majors Plan U.S. Manufacturing Investment Ami...September 23, 2025
Explore Our Enery Industry Reports
Gain the competitive edge with IIR Energy’s suite of energy market reports, designed for traders, analysts, and asset managers who rely on verified, real-time data.
View ReportsIndustry Intel
-
Innovations Shaping the Next Era of Power GenerationPodcast Episode / May 22, 2026
-
The Role of Contract Manufacturing in Global Pharma GrowthPodcast Episode / May 8, 2026
-
2026 North American Labor OutlookPodcast Episode / Apr 24, 2026
-
2026 European Metals & Minerals Project Spending OutlookPodcast Episode / Apr 7, 2026
-
The Age of Critical Minerals in the AmericasPodcast Episode / Mar 20, 2026